Company intelligence / Profile preview

V-Wave

Caesarea, Israel

Ownership: Private
Employees: ~80
Development stage: Other

Overview

V-Wave is a medical device company dedicated to developing innovative treatment options for patients living with heart failure. The company's primary product is the Ventura Interatrial Shunt, a minimally invasive, catheter-implanted device designed to reduce elevated left atrial pressure by creating a small opening between the left and right atria. This shunt aims to prevent pulmonary congestion and improve exercise capacity in patients with both reduced and preserved ejection fraction. In August 2024, Johnson & Johnson announced the acquisition of V-Wave to integrate its technology into the J&J MedTech cardiovascular portfolio.

Therapeutic areas: Cardiovascular
Modalities: DeviceInteratrial Shunt
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on V-Wave.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-Wave.

Explore the full profile